This study investigates pancreatic cancer. The purpose of this study is to evaluate the effectiveness and safety of investigational medications combined with other treatments for locally advanced or metastatic pancreatic cancer.
The study focuses on understanding how these investigational medications work together with existing treatments to manage pancreatic cancer. It evaluates the combination's effects on the body to ensure it is safe and effective for patients.
- Who can participate: Adults aged 18 to 75 with confirmed locally advanced or metastatic pancreatic cancer who have not received prior treatment for this stage may be eligible. Participants should have a good physical status and at least one measurable lesion.
- Study details: Participants will receive investigational medications along with standard treatments. Some may receive a placebo.
How understandable was the trial content above?
Hard to understand
Easy to understand